clinical trial · NCT06144060
A Trial of Intravenous HRS-8427 in the Treatment of Adults With Complicate Urinary Tract Infection, Including Acute Pyelonephritis
Jiangsu HengRui Medicine Co., Ltd.·phase2·unknown·n = 126
Patients With Complicated Urinary Tract Infection(cUTI), Including Acute Pyelonephritis(AP)HRS -8427Imipenem and Cilastatin Sodium
brief summary
The Purpose of this study is to evaluate the efficacy and safety of intravenous HRS -8427 in patients with complicated urinary tract infection, including acute pyelonephritis.
started
Dec 1, 2023
primary completion
Jun 1, 2024
completion
Jul 1, 2024
last updated
Nov 22, 2023
official title
A Multi-center, Randomized, Double-blind, Active Controlled, Parallel Groups, Phase II Study to Evaluate the Efficacy and Safety of Intravenous HRS-8427 in the Treatment of Adults With Complicate Urinary Tract Infection, Including Acute Pyelonephritis
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol